Filtered By:
Source: Tumor Biology
Cancer: Rhabdomyosarcoma

This page shows you your search results in order of date.

Order by Relevance | Date

Total 1 results found since Jan 2013.

FOXM1 expression in rhabdomyosarcoma: a novel prognostic factor and therapeutic target
This study aimed to determine the role of FOXM1 in RMS. We investigated the expression levels of FOXM1 and vascular endothelial growth factor (VEGF) and angiogenesis in a large series of RMS clinical cases using immunohistochemistry (nā€‰=ā€‰92), and we performed clinicopathologic and prognostic analyses. In vitro studies were conducted to examine the effect of FOXM1 knock-down on VEGF expression, cell proliferation, migration, and invasion in embryonal RMS (ERMS) and alveolar RMS (ARMS) cell lines, using small interference RNA (siRNA). High FOXM1 expression was significantly increased in the cases of ARMS, which has an ad...
Source: Tumor Biology - November 9, 2015 Category: Cancer & Oncology Source Type: research